1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9 Ack1

Results for "2247950-42-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-136220A
    AHR antagonist 5 hemimaleate

    Aryl Hydrocarbon Receptor Cancer
    AHR antagonist 5 hemimaleate, a potent and orally active aryl hydrocarbon receptor (AHR) antagonist, has an IC50 of < 0.5 µΜ. AHR antagonist 5 hemimaleate significantly inhibits tumor growth combined with checkpoint inhibitor anti-PD-1 (WO2018195397, example 39).
  • HY-136220
    AHR antagonist 5

    Aryl Hydrocarbon Receptor Cancer
    AHR antagonist 5, a potent and orally active aryl hydrocarbon receptor (AHR) antagonist extracted from patent WO2018195397, example 39, has an IC50 of < 0.5 µΜ. AHR antagonist 5 significantly inhibits tumor growth combined with checkpoint inhibitor anti-PD-1.
  • HY-141609
    AHR antagonist 5 free base

    Aryl Hydrocarbon Receptor Cancer
    AHR antagonist 5 free base is a selective and orally active aryl hydrocarbon receptor (AHR) inhibitor. AHR antagonist 5 free base effectively blocks AHR from translocating from the cytoplasm to the nucleus. AHR antagonist 5 free base is highly selective for AHR over other receptors, transporters, and kinases.